Valeant Pharmaceuticals International (NYSE:VRX)

CAPS Rating: 4 out of 5

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.

Results 1 - 20 of 48 : 1 2 3 Next »

Recs

0
Member Avatar clangmead (22.00) Submitted: 3/29/2015 4:33:29 PM : Outperform Start Price: $198.57 VRX Score: -0.36

eod

Recs

0
Member Avatar moneyman999 (47.89) Submitted: 2/15/2015 1:44:00 AM : Underperform Start Price: $168.17 VRX Score: -18.68

Simply overvalued,volitilty will be high but gains will be low.

Recs

0
Member Avatar freecapital (74.91) Submitted: 2/10/2015 11:37:21 PM : Outperform Start Price: $162.74 VRX Score: +21.25

Donville

Recs

0
Member Avatar 10x2 (56.92) Submitted: 1/30/2015 8:17:37 PM : Outperform Start Price: $158.00 VRX Score: +22.41

Sabrient pick.

Recs

0
Member Avatar reddingrunner (96.87) Submitted: 1/16/2015 1:33:28 PM : Outperform Start Price: $155.58 VRX Score: +23.75

sabrient bakers dozen 2015

Recs

0
Member Avatar 1russianguy (84.64) Submitted: 1/15/2015 9:17:14 AM : Outperform Start Price: $158.00 VRX Score: +22.41

Sabrient

Recs

0
Member Avatar mrudolph72 (60.37) Submitted: 1/14/2015 3:10:34 PM : Outperform Start Price: $157.00 VRX Score: +22.57

Sabrient

Recs

0
Member Avatar Defshark82 (71.03) Submitted: 12/31/2014 11:46:13 AM : Outperform Start Price: $143.88 VRX Score: +37.70

top pick JPM tracker

Recs

0
Member Avatar mlarms (< 20) Submitted: 7/31/2014 2:24:29 AM : Outperform Start Price: $118.88 VRX Score: +60.20

My big Pharma pick

Recs

0
Member Avatar TerryHoodSr (79.87) Submitted: 6/16/2014 10:58:46 AM : Outperform Start Price: $117.81 VRX Score: +61.05

VRX EPS 1YR 60% 3YR 50% 5YR 55%
CURR EPS 2.89 NEXT YR EPS 10.54
NEXT YR PE 11

Recs

0
Member Avatar chipotlepickle (98.42) Submitted: 6/15/2014 5:21:26 PM : Underperform Start Price: $118.81 VRX Score: -59.37

Running out of one time events.

Recs

0
Member Avatar ValueSwap (< 20) Submitted: 6/12/2014 3:29:27 PM : Outperform Start Price: $120.02 VRX Score: +57.41

How R&D should work and their aggressive capitalizing interest to generate a low tax rate create much fuzz about the company, which in turn give a long term holder a good entry point

Recs

0
Member Avatar IanERichards (84.96) Submitted: 6/4/2014 7:37:57 AM : Outperform Start Price: $131.15 VRX Score: +43.02

Focus on capital allocation - creative approach to making a deal

Recs

0
Member Avatar RickP (88.54) Submitted: 5/18/2014 6:17:33 PM : Outperform Start Price: $125.85 VRX Score: +46.61

Great CEO......

Fantastic future regardless of whether Allergen merger occurs or not

Recs

0
Member Avatar RLBOWERSOX (98.03) Submitted: 3/31/2014 4:40:45 PM : Outperform Start Price: $132.07 VRX Score: +39.22

One of the final four

Recs

0
Member Avatar mrwrong (< 20) Submitted: 3/29/2014 2:06:48 PM : Underperform Start Price: $129.27 VRX Score: -41.87

growth will stall as company comes a cropper, with a bridge too far. most all- do, but i like it now.

Recs

0
Member Avatar motto1628 (48.11) Submitted: 3/25/2014 4:05:57 PM : Outperform Start Price: $132.26 VRX Score: +38.66

- genius CEO in acquisition
- diversified pharmaceutical products
- stock advisor pick

Recs

0
Member Avatar mtbound (42.70) Submitted: 3/1/2014 12:25:37 PM : Outperform Start Price: $143.30 VRX Score: +25.82

I'm here mainly because of leadership. I've bought in to extraordinary leadership extracting value.

Recs

0
Member Avatar lapinkpanther (69.56) Submitted: 2/24/2014 2:58:06 PM : Outperform Start Price: $145.96 VRX Score: +23.86

Great Management!

Recs

0
Member Avatar bradrimm (64.64) Submitted: 2/9/2014 9:55:01 AM : Outperform Start Price: $138.21 VRX Score: +27.78

Strips dead wood. Value adding. Good macro scene

Results 1 - 20 of 48 : 1 2 3 Next »

Featured Broker Partners


Advertisement